baber/WOPTO huggingface dataset:
Patent AU-2003211144-B2 (AU)
Title: Modulatable power transmission clutch and a marine transmission
Inventor: CLARK ANDREW
IPC: F16D48/02
Filed: 2003-02-19
Granted: 2009-07-16
Abstract: A transmission housing having a modulatable power transmission therein which includes a clutch having interleaved clutch plates and having a central power transmitting shaft extending axially through the clutch. The clutch includes a fluid operated movable piston for effecting clutch operation by compression of the plates. The piston has a smaller piston area and a larger piston area, the smaller piston area has fluid flow directed to it at a variable fluid pressure whereby the clutch is modulatable. The larger piston area is adapted to have fluid flow directed thereto to effect maximum and unmodulatable engagement of the clutch. A spring loaded normally closed trigger valve controls fluid flow to the larger piston area in response to fluid pressure above a predetermined amount at the smaller piston area. The trigger valve is mounted on the outside of the transmission housing and is readily accessible for adjustment, for example. The trigger valve is normally closed so that pressure fluid is directed to the smaller piston area at a variable fluid pressure whereby the clutch is modulatable. When the valve is open by fluid pressure over a predetermined amount, the valve permits fluid flow to the larger piston area to effect maximum and unmodulatable engagement of the clutch for full clutch capacity.
Patent AU-2003300051-B2 (AU)
Title: Adaptive junk message filtering system
Inventor: HECKERMAN DAVID E
IPC: G06Q10/10
Filed: 2003-12-31
Granted: 2009-02-19
Abstract: The invention relates to a system for filtering messages-the system includes a seed filter having associated therewith a false positive rate and a false negative rate. A new filter is also provided for filtering the messages, the new filter is evaluated according to the false positive rate and the false negative rate of the seed filter, the data used to determine the false positive rate and the false negative rate of the seed filter are utilized to determine a new false positive rate and a new false negative rate of the new filter as a function of threshold. The new filter is employed in lieu of the seed filter if a threshold exists for the new filter such that the new false positive rate and new false negative rate are together considered better than the false positive and the false negative rate of the seed filter.
Patent AU-2004204502-B2 (AU)
Title: Method to form a protein microarray system
Inventor: LUBMAN DAVID M
IPC: C07K1/04
Filed: 2004-01-13
Granted: 2008-05-29
Abstract: The present invention relates to automated methods, systems, and apparatuses for protein separation and analysis. In particular, the present invention provides an automated system for the separation, identification, and characterization of protein samples. The present invention thus provides improved methods for the separation and analysis of samples containing a plurality of proteins (e.g., cells).
Patent AU-2004259362-B2 (AU)
Title: Glazing system
Inventor: LATHIEF ARAKKAL ABDUL KHADER ABDUL
IPC: E06B3/58
Filed: 2004-07-15
Granted: 2010-06-24
Abstract: The current invention relates to a unique and compact self-lock glazing mechanism for heavy glazing needs, composed of two aluminum extrusion profiles—a male profile and a female profile—designed in such a way to self-lock glass panels using rubber beading; the said glazing system functions when glass panel is placed on the setting blocks over the upper leg of the said female profile with a pair of spacers between the vertical tip of the said female profile and the said glass panel, and then the horizontal leg of the said male profile is inserted with its locking tip facing upward into the gap between the lower and upper legs of the said female profile; the locking tips of both the male and female profiles are then engaged by tilting the said male profile on its built-in fulcrum by pulling the vertical leg outward and introducing a pair of wedges into the space so created between the said glass panel and the said vertical tip of the male profile to keep the lock engaged and the said profiles get arrested; eventually the said glass panel is locked in the said glazing system; and the said mechanism further tightens its grip on the edges of the locked glass panel when the spacers and wedges are replaced by grooved rubber beadings of appropriate resilience which enables the said glass panel to remain in equilibrium throughout the life of the rubber beading; the introduction of the rubber beadings into the system lends a unique dynamism to the mechanism due to the built in fulcrum built in the said male profile, the inherent resilience of rubber causes a mating action in the said locking chamber and the resulting equal and opposite reaction keep the glass panel in an equilibrium; this balancing act of forces remains in the locking system throughout the life of the rubber beading as a dynamic phenomenon.
Patent AU-2004297218-B2 (AU)
Title: Human anti-Pseudomonas-aeruginosa antibodies derived from transgenic Xenomouse
Inventor: SCHREIBER JOHN R
IPC: A61P27/16
Filed: 2004-12-03
Granted: 2012-03-01
Abstract: The invention described herein provides for human antibodies produced in non-human animals that specifically bind to lipopolysaccharide (LPS) from strains Fisher Devlin (International Serogroups) It-2 (011), It-3 (02), It-4 (01), It-5 (010), It-6 (07), PA01 (05), 170003 (02), IATS016 (02/05), and 170006 (02). The invention further provides methods for making the antibodies in a non-human animal, expression of the antibodies in cell lines including hybridomas and recombinant host cell systems. Also provided are kits and pharmaceutical compositions comprising the antibodies and methods of treating or preventing pseudomonas infection by administering to a patient the pharmaceutical compositions described herein.
Patent AU-2005200916-B2 (AU)
Title: Gaming machine with payout table
Inventor: HIDEAKI IWAMOTO
IPC: A63F5/04
Filed: 2005-02-28
Granted: 2011-08-18
Abstract: A slot machine comprising a payout display device, which performs a high display effect, is provided. The slot machine 1 is provided with a sub 5 display 3. The sub display 3 displays a payout table showing payout information about payout amount distributed to a player depending on the number of coins bet by the player and the winning combination. Selected Drawing: Fig. 38 ARF-082 Fig. 38 [Payout Display Change Command Reception Processing] Payout Display Change Pattern ~S251 Probability Lottery Processing Rotation Display Of Payout Display ~S252 Of Relevant Bet Number Is Started Rotation Display Is Stopped, And Paytable Based On Selected Payout S253 Change Pattern Is Displayed Identifiable Display Of Payout Display S254 Of Relevant Bet Number Is Started
Patent AU-2005205229-B2 (AU)
Title: Process for the production of asymmetric transformation catalysts
Inventor: WHITTALL JOHN
IPC: C07F17/02
Filed: 2005-01-14
Granted: 2010-03-04
Abstract: The present invention relates to metallocene-based phosphine ligands having chirality at phosphorus and at least one other element of chirality (planar chirality and/or chirality at carbon); and to the use of such ligands in asymmetric transformation reactions to generate high enantiomeric excesses of formed compounds. A method for the preparation of ligands according to the invention involving the conversion of the ortho-lithiated substituted metallocene to a phosphine chiral at phosphorus is also disclosed.
Patent AU-2005212106-B2 (AU)
Title: Sternum reinforcing device to be used after a sternotomy or a sternal fracture
Inventor: JACOB ZEITANI
IPC: A61B17/80
Filed: 2005-02-15
Granted: 2011-06-23
Abstract: A sternum reinforcing device to be used after a sternotomy or a sternal fracture, made of a biocompatible material, comprises an elongated modular member (10) with a pair of legs (20, 30), that are joined each other by a body portion (4), and a pair of arms (6, 7). The legs (20, 30) can be fitted in an intercostal space of the thorax of a patient, laterally to the sternum, and can be bent in a mutually opposite direction, on the internal side of the thorax, after being fitted therein. The arms (6, 7), extending from one side to the other of the body portion (4) and orthogonally to the pair of legs (20, 30), constitute a male part and a female part, respectively, of a prismatic type coupling for consecutive modular members.
Patent AU-2005231476-B2 (AU)
Title: Il-28 and il-29 cysteine mutants for treating viral infection
Inventor: KLUCHER KEVIN M
IPC: C07K14/54
Filed: 2005-04-04
Granted: 2011-09-01
Abstract: IL-28A, IL-28B, IL-29, and certain mutants thereof have been shown to have antiviral activity on a spectrum of viral species. Of particular interest is the antiviral activity demonstrated on viruses that infect liver, such as hepatitis B virus and hepatitis C virus. In addition, IL-28A, IL-28B, IL-29, and mutants thereof do not exhibit some of the antiproliferative activity on hematopoietic cells that is observed with interferon treatment. Without the immunosuppressive effects accompanying interferon treatment, IL-28A, IL-28B, and IL-29 will be useful in treating immunocompromised patients for viral infections.
Patent AU-2005236504-B2 (AU)
Title: Method, system and software product for color image encoding
Inventor: YANG EN-HUI
IPC: H04N7/26
Filed: 2005-04-15
Granted: 2010-02-25
Abstract: The present invention relates to the compression of color image data. A combination of hard decision pixel mapping and soft decision pixel mapping is used to jointly address both quantization distortion and compression rate while maintaining low computational complexity and compatibility with standard decoders, such as, for example, the GIF/PNG decoder.
Patent AU-2005254736-B2 (AU)
Title: Oligomeric peptides and their use for the treatment of HIV infections
Inventor: FRANK KIRCHHOFF
IPC: A61K38/55
Filed: 2005-06-17
Granted: 2011-08-18
Abstract: The invention relates to oligomeric peptides with biological activity against HIV infection having the amino acid sequence (Z-LEX X-X-P-X5-X-X-X- X-X-K-X-X-X-X-X-Z), wherein n indicates the number of monomeric peptide chains, whereby n is 2, 3 or 4; X is a lysine, alanine, or aspartic acid; X is a cysteine, methionine or isoleucine; X is a serine, cysteine, lysine or glycine; X is an isoleucine, alanine, phenylalanine or cysteine; X5 is a proline, D-proline or a substituted L-or D-proline; X is a cysteine or glutamic acid; X is an amino acid with a hydrophobic or an aromatic side chain or cysteine; X is an amino acid with a hydrophobic or an aromatic side chain or cysteine; X is an amino acid with an aromatic side chain; X is a glycine, alanine or asparagine; X is a proline, aspartic acid, octahydroindolyl-2-carboxylic acid or D­1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; Xis a phenylalanine, alanine, glycine, glutamic acid or D-1,2,3,4­tetrahydroisoquinoline-3-carboxylic acid; Xis an amino acid with a hydrophobic or an aromatic side chain; Xis an amino acid with a hydrophobic or an aromatic side chain; X is a phenylalanine or deletion; Z is NH or a sequence of 1 to 10 amino acid residues; Z is COOH or a sequence of 1 to 10 amino acid residues; and oligomeric peptides which are fragments thereof and/or derivatives, especially amidated, alkylated, acylated, sulfated, pegylated, phosphorylated and/or glycosylated derivatives, and mutants thereof; and with the proviso that (a) if Xis alanine, glycine, glutamic acid, or D-1,2,3,4­tetrahydroisoquinoline-3-carboxylic acid than X, X and Xare phenylalanine, valine and phenylalanine respectively; and/or (b) if Xis phenylalanine, than X, X and Xare valine, phenylalanine and a deletion, respectively; and (c) there are at maximum three cysteine residues in a peptide; and (d) the oligomeric peptide has not the sequence (LEAIPCSIPPEFLFGKPFVF) (VIR-576); and (e) the monomeric peptide chains are not linked by peptide bonds between the N- terminus of one peptide chain to the C-terminus of another peptide chain.
Patent AU-2005306167-B2 (AU)
Title: Compensation of simple fiberoptic faraday effect sensors
Inventor: BJORN LARS NORGAARD
IPC: G01R31/02
Filed: 2005-11-18
Granted: 2010-07-22
Abstract: A monitoring system for detecting earth faults in an electrical power supply grid providing a power signal includes a plurality of monitoring devices, each of the monitoring devices including a detector for detecting the level of harmonics in the power signal, wherein the level of harmonics is detected in a specific frequency range. Each of the monitoring devices further includes a memory for storing a harmonics reference value, a processor for comparing the detected level of harmonics with the reference level, and a communication device for transmitting an alarm if the detected level of harmonics is above the reference level for a specific period of time. Each of the detectors includes an optical sensor for detecting the harmonics by use of the Faraday effect.
Patent AU-2005317986-B2 (AU)
Title: Stabilisation of radiopharmaceutical precursors
Inventor: ANTHONY WILSON
IPC: C07H5/02
Filed: 2005-11-18
Granted: 2011-08-11
Abstract: The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-ß-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
Patent AU-2005323408-B2 (AU)
Title: Absorbent article packaging
Inventor: BOLDRA JAMES A
IPC: A61F13/15
Filed: 2005-09-30
Granted: 2011-09-08
Abstract: A package containing an article. The article includes a first article texture and a second article texture. The package includes a plastic packaging material having an outer surface. Further the first article texture and the second article texture are non-similar and at least a portion of the outer surface has a packaging texture that is a simulant of the first article texture and at least a portion of the outer surface has a packaging texture that is a simulant of the second article texture.
Patent AU-2006220187-B2 (AU)
Title: Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
Inventor: VOCADLO DAVID
IPC: C07D309/14
Filed: 2006-03-01
Granted: 2012-11-08
Abstract: The invention comprises compounds for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions containing the compounds or prodrugs of the compounds. The invention also comprises animal models and methods of making the animal models for studying diseases and disorders related to deficiency or overexpression of O-GIcNAcase, accumulation or deficiency of O-GIcNAc, and treatment of such diseases and disorders. The invention also comprises methods of treating such diseases and disorders. The invention also comprises methods of making the compounds, and methods of making selective glycosidase inhibitors.
Patent AU-2006238895-B2 (AU)
Title: Evaluating bacterial lethality of containerized food production
Inventor: MCCAULEY KURTIS J
IPC: G01N35/00
Filed: 2006-04-25
Granted: 2011-08-11
Abstract: Procedures and means for evaluating effectiveness of bacterial -lethality, following batch-processed containerized food production operations and aseptic-flow food-production operations as containerized in aseptic- containers, in preparing for non- refrigerated marketing are described. The evaluations significantly expedite determining whether thermally-processed containerized food- production is safe for non-refrigerated marketing. The presence or absence of live spore- forming bacteria is determined chemically free of extended storage requirements relying on a mechanical -failure indication of food- spoilage. Also, a biological-indication verification of microbial- biocidal status of the packaged food is made available. The invention determines whether rigid- sheet metal containers, and/or whether any of the new, and newly developing, non- refrigerated food packages, which largely utilize polymeric materials, for convenient microwave -oven heating of opened- packs, and soft polymeric pouch products, are safe for non- refrigerated marketing; and, such determinations are made substantially more concurrently with production-operations, than previously available.
Patent AU-2006266564-B2 (AU)
Title: A breathing assistance apparatus with a manifold to add auxiliary gases to ambient gases
Inventor: O'DONNELL KEVIN PETER
IPC: A62B7/02
Filed: 2006-06-29
Granted: 2012-03-22
Abstract: The breathing assistance apparatus of the present invention includes a manifold that is provided with or retrofittable to gases supply and humidifying devices. The manifold allows gases from an oxygen concentrator to be combined with the flow through a gases supply and humidifying device, most usually air. The combined output of oxygen and other breathing gases (air) is then humidified. The breathing assistance apparatus and manifold of the present invention provides a safe method to add oxygen to the input air stream of a gases supply and humidifying device and reduces the amount of accumulation of oxygen within the gases supply device, reducing fire risk should sparking occur within the device.
Patent AU-2006307457-B2 (AU)
Title: Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same
Inventor: YELIN RODRIGO
IPC: C12N15/82
Filed: 2006-10-24
Granted: 2012-03-22
Abstract: Nucleic acid constructs are provided. These constructs comprise any of the , nucleic acid sequences at least 85 % identical to nucleotide sequences selected from the group consisting of SEQ ID NOs: 68, 1, 4, 5, 8, 9, 11, 13, 16, 19, 20, 23, 24, 27, 30, 32, 37, 42, 49, 50, 51, 53, 54, 55, 56, 57, 58, 64, 69, 70, 73, 77, 78, 79, 80, 84, 86, 87, 93, 94, 98, 101, 102, 103, 104, 105, 106, 107, 108 and 109 and a promoter sequence capable of directing transcription of said nucleic acid sequence in a host cell. Also provided are transgenic plants expressing these nucleic acid constructs and methods of using same
Patent AU-2006307600-B2 (AU)
Title: Adjustable vaginal splint for pelvic floor support
Inventor: BURKHARD PETERS
IPC: A61F2/00
Filed: 2006-10-24
Granted: 2011-10-20
Abstract: Vaginal splints and methods for their use for treating various pelvic floor conditions are provided. One embodiment of the vaginal splint includes a base portion having a configuration defined by first and second sides, a first connecting portion at a proximal side of the base portion and extending between a first end of each of the first and second sides, and a second connecting portion at a distal side of the base portion and extending between a second end of each of the first and second sides. The splint further includes an adjustable portion coupled to the base portion and positioned substantially adjacent to and distal of the second connecting portion of the base portion. The adjustable portion is removable by a user to thereby change the size of the splint.
Patent AU-2006311226-B2 (AU)
Title: Method for the operation of a shaft furnace, and shaft furnace suitable for said method
Inventor: KONIG GERD
IPC: F27B1/16
Filed: 2006-11-09
Granted: 2010-09-09
Abstract: Apparatus for operating a shaft furnace, whereby an upper section of the shaft furnace is charged with raw materials which due to gravity descend inside the furnace while the atmosphere prevailing within the shaft furnace causes part of the raw materials to melt and/or to be reduced, and in a lower section of the shaft furnace a process gas is injected so as to at least partly modify the atmosphere prevailing in the shaft furnace. The pressure and/or volume flow of the injected process gas is dynamically modulated within a time span of 40 s. Also, a shaft furnace operable by said method, thus achieving improved through-gassing.
Patent AU-2006331635-B2 (AU)
Title: Lubricating oil with high oxidation stability
Inventor: BERTRAND NANCY J
IPC: C10G35/00
Filed: 2006-12-19
Granted: 2011-07-14
Abstract: A lubricating oil (made from Group III base oil having a sequential number of carbon atoms) having a VI between 155 and 300, a RPVOT greater than 680 minutes, and a kinematic viscosity at 40°C from 19.8 cSt to 748 cSt. A lubricating oil having a high Vl and high RPVOT comprising: a) a Group III base oil with a sequential number of carbon atoms, and defined cycloparaffin composition or low traction coefficient, b) an antioxidant additive concentrate and c) no Vl improver, A process comprising: a) hydroisomerization dewaxing of a waxy feed, b) fractionating the produced base oil, c) selecting a fraction having a Vl greater than 150, and a high level of molecules with cycloparaffin ic functionality or a low traction coefficient, and d) blending the fraction with an antioxidant additive concentrate. Also, a method of improving the oxidation stability of a lubricating oil.
Patent AU-2006347391-B2 (AU)
Title: Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate
Inventor: YU CHONGXI
IPC: C07D491/04
Filed: 2006-08-15
Granted: 2013-03-07
Abstract: The novel positively charged pro-drugs of aryl- and heteroarylpropionic acids in the general formula (1) 'Structure 1' and general formula (2) 'Structure 2' were designed and synthesized. The compounds of the general formula (1) 'Structure 1' and general formula (2) 'Structure 2' indicated above can be prepared from functional derivatives of naproxen, suprofen, α- methyl-(p-chlorobenzoyl)-5-methoxy-2-methylindole 3-acetic acid, flurbiprofen, carprofen, pranoprofen, benoxaprofen, alminoprofen, tiaprofenic acid, pirprofen, zaltoprofen, bermoprofen, loxoprofen, indoprofen, fenclorac, oxaprozin, fenbufen, orpanoxin, ketorolac, clidanac, and related compounds, (for example acid halides or mixed anhydrides), by reaction with suitable alcohols, thiols, or amines. The positively charged amino groups of these pro-drugs not only largely increases the solubility of the drugs, but also bonds to the negative charge on the phosphate head group of membranes and pushes the pro-drug into the cytosol. The results suggest that the pro-drugs diffuses through human skin -100-130 times faster than do their parent drugs. It takes 2-4 hours for naproxen, suprofen, α- methyl-(p-chlorobenzoyl)-5-methoxy-2-methylindole 3-acetic acid, flurbiprofen, carprofen, pranoprofen, benoxaprofen, alminoprofen, tiaprofenic acid, pirprofen, zaltoprofen, bermoprofen, loxoprofen, indoprofen, fenclorac, oxaprozin, fenbufen, orpanoxin, ketorolac, clidanac, and related compounds to reach the peak plasma level when they are taken orally, but these prodrugs only took about 40-50 minutes to reach the peak plasma level when they are taken transdermally. In plasma, more than 90% of these pro-drugs can change back to the drug in a few minutes. The prodrugs can be used medicinally in treating any NS AIAs-treatable conditions in humans or animals. The prodrugs can be administered not only orally, but also transdermally for any kind of medical treatments and avoid most of the side effects of NSAIAs, most notably GI disturbances such as dyspepsia, gastroduodenal bleeding, gastric ulcerations, and gastritis. Controlled transdermal administration systems of the prodrugs enable naproxen, suprofen, α- methyl-(p-chlorobenzoyl)-5-methoxy-2-methylindole 3-acetic acid, flurbiprofen, carprofen, pranoprofen, benoxaprofen, alminoprofen, tiaprofenic acid, pirprofen, zaltoprofen, bermoprofen, loxoprofen, indoprofen, fenclorac, oxaprozin, fenbufen, orpanoxin, ketorolac, clidanac, and related compounds to reach constantly optimal therapeutic blood levels to increase effectiveness and reduce the side effects of NSAIAs. Another great benefit of transdermal administration of these pro-drugs is that administering medication, especially to children, will be much easier.